Ming Y Lim: Demonstrating the Value of Upfront Emicizumab at ISTH 2026
Ming Y Lim, Clinical Associate Professor at the University of Utah, shared on LinkedIn:
”What makes ISTH special is the people.
Every meeting is an opportunity to connect with colleagues across disciplines, exchange ideas, learn from one another, and build collaborations that ultimately improve outcomes for patients around the world.
At ISTH 2026 in Paris, I had the privilege of presenting at the SSC Factor VIII, Factor IX, and Rare Coagulation Disorders Subcommittee led by Susan Shapiro, met with the Dengue Infection in Congenital Bleeding Disorders Working Group led by Nongnuch-Nong Sirachainan, and presenting a poster on the cost-effectiveness of upfront emicizumab use in hospitalized patients with acquired hemophilia A.
Judging by the photo, I was clearly having fun engaging with colleagues who stopped by the poster and shared their insights and questions!
Spoiler alert: Adding upfront emicizumab to standard of care was both more effective and less costly, even at current emicizumab pricing.
So grateful for the opportunity to learn from and collaborate with so many outstanding colleagues, and proud to be part of the ISTH community.”
Stay updated with Hemostasis Today.
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause